NepMeds
‌

OXYSPAS-2.5MG

CIPLA
(SKU-72-6552)The contents provided in this website are for informational purposes only. We here do not intend to be substitute of medical personnel advice, diagnosis or any kind of treatments. Please take in consideration of a physician for any kind of queries regarding your health concern. Meanwhile, please do not disregard those medical advices because of what you read on this website.
0/5
|
0 ratings
&
reviews
Price :

Rs. 0

Quantity :
PCS
of 1
Out of Stock

Product Overview

Composition: Oxybutynin (2.5mg)

 

Oxyspas 2.5 Tablet is used in the treatment of overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate, and inability to control urination. Oxyspas 2.5 Tablet is advised to take it in a dose and duration as per prescription. It should be taken on an empty stomach at least an hour before having a meal. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms.

 

 

 

Uses

Treatment of Overactive bladder (OAB) symptoms

Side Effect

Common side effects:

Dryness in mouth
Constipation
Diarrhea

  • Blurred vision
  • Dry skin
  • Dizziness
  • Headache
  • Sleepiness

How to use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Oxyspas 2.5 Tablet is to be taken empty stomach.

How It works

Oxyspas 2.5 Tablet is an antimuscarinic. It works by relaxing muscles of the urinary bladder and prevents frequent, urgent or uncontrolled urination.

Safety Advice for OXYSPAS-2.5MG

Alcohol

Oxyspas 2.5 Tablet may cause excessive drowsiness with alcohol.

Pregnacy

Oxyspas 2.5 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies

Breastfeeding

Oxyspas 2.5 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Frequently Asked Questions

‌
‌
‌
‌
‌
‌
‌
‌